PERRI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 188
EU - Europa 81
AS - Asia 11
AF - Africa 2
SA - Sud America 2
Totale 284
Nazione #
US - Stati Uniti d'America 183
IT - Italia 49
DE - Germania 15
CA - Canada 5
SE - Svezia 5
FR - Francia 4
TH - Thailandia 3
CL - Cile 2
CN - Cina 2
UA - Ucraina 2
BE - Belgio 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HU - Ungheria 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
PH - Filippine 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 284
Città #
Santa Cruz 38
Rome 24
Buffalo 12
Fairfield 12
Seattle 7
Woodbridge 7
Houston 6
San Diego 6
Des Moines 5
Frankfurt Am Main 5
Munich 5
Vancouver 5
Ashburn 4
Stockholm 4
Wilmington 4
Avellino 3
Bangkok 3
Henderson 3
Ann Arbor 2
Bologna 2
Dallas 2
Los Angeles 2
Milan 2
Mountain View 2
Padova 2
Andover 1
Beijing 1
Berlin 1
Bolzano 1
Boston 1
Bottrop 1
Budapest 1
Cagliari 1
Cambridge 1
Chicago 1
Chions 1
Duncan 1
Hamburg 1
Indianapolis 1
Izmir 1
Jacksonville 1
Kalamazoo 1
Kirkland 1
Lahug 1
Linköping 1
Marseille 1
Muizenberg 1
Nagold 1
Nîmes 1
Palo Alto 1
Paris 1
Peschiera Borromeo 1
Phoenix 1
Providence 1
Provo 1
Riyadh 1
Saint Petersburg 1
Salem 1
San Jose 1
San Mateo 1
San Vittore Olona 1
Seoul 1
Shanghai 1
South Bend 1
Surbo 1
Taipei 1
Totale 208
Nome #
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis, file e3835325-390c-15e8-e053-a505fe0a3de9 79
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study, file e383532d-cc28-15e8-e053-a505fe0a3de9 64
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia, file e383532b-5a09-15e8-e053-a505fe0a3de9 51
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study, file e383532d-0b1f-15e8-e053-a505fe0a3de9 44
Major reduction of NKT cells in patients with severe COVID-19 pneumonia, file e3835328-5206-15e8-e053-a505fe0a3de9 42
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease, file e383532c-c8bb-15e8-e053-a505fe0a3de9 9
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine, file 8365fd98-74b0-41a3-8e6e-8eeda9098e70 4
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia, file e3835327-c50d-15e8-e053-a505fe0a3de9 3
X Seminar- PhD day. Science for Democracy- Democracy for Science. PhD day Infectious Diseases, Microbiology and Public Health. Istituto Superiore di Sanità., file e3835326-bcf0-15e8-e053-a505fe0a3de9 1
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality, file e383532d-e9ec-15e8-e053-a505fe0a3de9 1
Totale 298
Categoria #
all - tutte 432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0000 00 00 1231
2020/202133 4402 04 22 4137
2021/2022144 50103 109 1419 8133617
2022/2023114 623821 816 230 0000
Totale 298